Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.
作者信息
Kirkham B
机构信息
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Australia.
出版信息
Ann Rheum Dis. 1991 Jun;50(6):395-400. doi: 10.1136/ard.50.6.395.
Abstract
摘要
相似文献
1
Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.白细胞介素-1、免疫激活途径以及骨关节炎和类风湿关节炎中的不同机制。
Ann Rheum Dis. 1991 Jun;50(6):395-400. doi: 10.1136/ard.50.6.395.
2
[Detection of interleukin 1 activity in synovial fluid in rheumatoid arthritis and osteoarthritis].[类风湿性关节炎和骨关节炎患者滑液中白细胞介素1活性的检测]
Beitr Orthop Traumatol. 1988 Dec;35(12):612-6.
3
4
Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.细胞因子与风湿性疾病的慢性炎症。I. 滑液中白细胞介素-1的存在。
Clin Exp Immunol. 1984 Feb;55(2):295-302.
5
Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.滑液中的细胞因子。I. 生物活性和免疫反应性白细胞介素-1的存在
Clin Exp Immunol. 1988 Jun;72(3):422-7.
6
Cytokines and cellular interactions in inflammatory synovitis.炎症性滑膜炎中的细胞因子与细胞相互作用
J Clin Invest. 2001 May;107(9):1081-2. doi: 10.1172/JCI12952.
7
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis.全血中细胞因子（IL-1β、TNF-α、IL-6、IL-2、IFN-γ和GM-CSF）的直接刺激：II. 在类风湿性关节炎和骨关节炎中的应用。
Cytokine. 1992 Nov;4(6):568-75. doi: 10.1016/1043-4666(92)90021-i.
8
Bone resorbing activity in synovial fluids in destructive osteoarthritis and rheumatoid arthritis.破坏性骨关节炎和类风湿关节炎滑液中的骨吸收活性。
Ann Rheum Dis. 1988 Mar;47(3):198-205. doi: 10.1136/ard.47.3.198.
9
Canine rheumatoid arthritis and inflammatory cytokines.犬类风湿性关节炎与炎性细胞因子
Vet Immunol Immunopathol. 1999 Aug 2;69(2-4):201-14. doi: 10.1016/s0165-2427(99)00054-9.
10
[Synovial level of interleukin 1 and C3a in chronic polyarthritis, psoriatic arthritis and activated arthritis].[慢性多关节炎、银屑病关节炎及活动性关节炎中白细胞介素1和C3a的滑膜水平]
Z Rheumatol. 1988 Jan-Feb;47(1):20-5.
引用本文的文献
1
Immunotherapies in chronic pain through modulation of neuroimmune interactions.通过调节神经免疫相互作用治疗慢性疼痛的免疫疗法。
Pharmacol Ther. 2023 Aug;248:108476. doi: 10.1016/j.pharmthera.2023.108476. Epub 2023 Jun 10.
2
Drug repositioning: diacerein as a new therapeutic approach in a mice model of sciatic nerve injury.药物重新定位：双醋瑞因作为坐骨神经损伤小鼠模型中的一种新治疗方法。
Pharmacol Rep. 2023 Apr;75(2):358-375. doi: 10.1007/s43440-023-00461-9. Epub 2023 Feb 21.
3
A bibliometrics analysis and visualization of osteoimmunology on osteoarthritis studies.骨免疫学在骨关节炎研究中的文献计量学分析与可视化
Am J Transl Res. 2022 Jun 15;14(6):4260-4277. eCollection 2022.
4
Benefit-risk assessment of diacerein in the treatment of osteoarthritis.双醋瑞因治疗骨关节炎的效益-风险评估。
Drug Saf. 2015 Mar;38(3):245-52. doi: 10.1007/s40264-015-0266-z.
5
Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines.合成查尔酮衍生物作为分泌型磷脂酶A2、环氧化酶、脂氧合酶和促炎细胞因子潜在抑制剂的研究
Drug Des Devel Ther. 2014 Sep 16;8:1405-18. doi: 10.2147/DDDT.S67370. eCollection 2014.
6
Analgesic, anti-inflammatory, and chondroprotective activities of Cryptolepis buchanani extract: in vitro and in vivo studies.布氏白叶藤提取物的镇痛、抗炎和软骨保护活性：体外和体内研究
Biomed Res Int. 2014;2014:978582. doi: 10.1155/2014/978582. Epub 2014 Aug 27.
7
The roles of catabolic factors in the development of osteoarthritis.分解代谢因子在骨关节炎发展中的作用。
Tissue Eng Part B Rev. 2014 Aug;20(4):355-63. doi: 10.1089/ten.TEB.2013.0377. Epub 2013 Dec 11.
8
The problem of choice: current biologic agents and future prospects in RA.选择的问题：类风湿关节炎的当前生物制剂和未来前景。
Nat Rev Rheumatol. 2013 Mar;9(3):154-63. doi: 10.1038/nrrheum.2013.8. Epub 2013 Feb 19.
9
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.西普乐他赛免疫参数与生存相关：一项针对去势抵抗性前列腺癌男性的随机 3 期临床试验分析。
Cancer Immunol Immunother. 2013 Jan;62(1):137-47. doi: 10.1007/s00262-012-1317-2. Epub 2012 Aug 3.
10
Polyoxypregnane glycoside from Dregea volubilis extract inhibits IL-1β-induced expression of matrix metalloproteinase via activation of NF-κB in human chondrocytes.三叶崖爬藤提取物中的五环三萜糖苷通过激活 NF-κB 抑制人软骨细胞中 IL-1β 诱导的基质金属蛋白酶表达。
In Vitro Cell Dev Biol Anim. 2012 Jan;48(1):43-53. doi: 10.1007/s11626-011-9475-7. Epub 2011 Dec 18.
本文引用的文献
1
Macrophage-derived growth factor for osteoblast-like cells and chondrocytes.巨噬细胞衍生的成骨样细胞和软骨细胞生长因子。
Proc Natl Acad Sci U S A. 1984 Jul;81(14):4558-62. doi: 10.1073/pnas.81.14.4558.
2
Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.细胞因子与风湿性疾病的慢性炎症。I. 滑液中白细胞介素-1的存在。
Clin Exp Immunol. 1984 Feb;55(2):295-302.
3
Relation of cellular infiltration of rheumatoid synovial membrane to its immune response.类风湿性滑膜的细胞浸润与其免疫反应的关系。
Arthritis Rheum. 1974 May-Jun;17(3):313-9. doi: 10.1002/art.1780170317.
4
Identification of a membrane-associated interleukin 1 in macrophages.巨噬细胞中一种膜相关白细胞介素1的鉴定。
Proc Natl Acad Sci U S A. 1985 Feb;82(4):1204-8. doi: 10.1073/pnas.82.4.1204.
5
Inducible interleukin-1 gene expression in human vascular smooth muscle cells.人血管平滑肌细胞中白细胞介素-1基因的诱导表达
J Clin Invest. 1986 Dec;78(6):1432-8. doi: 10.1172/JCI112732.
6
Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide.白细胞介素-1在先前被肽聚糖-多糖损伤的大鼠关节中加重关节炎。
J Immunol. 1988 May 1;140(9):2964-9.
7
Biology of interleukin 1.白细胞介素1的生物学特性
FASEB J. 1988 Feb;2(2):108-15.
8
Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.白细胞介素-1β和蛋白聚糖的滑液浓度呈负相关。
J Autoimmun. 1988 Aug;1(4):373-80. doi: 10.1016/0896-8411(88)90007-8.
9
Production of interleukin 1 in the joint during the development of antigen-induced arthritis in the rabbit.兔抗原诱导性关节炎发展过程中关节内白细胞介素1的产生
Clin Exp Immunol. 1988 Dec;74(3):371-6.
10
Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.类风湿关节炎中白细胞介素-1和肿瘤坏死因子信使核糖核酸的表达：白细胞介素-1α的持续产生
Clin Exp Immunol. 1988 Sep;73(3):449-55.
Zotero 插件